Skip to content

SILO PHARMA, INC.: filings

Every SILO PHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026361060001213900-26-089085
10-Q2026-05-14fiscal Q1 202634720001213900-26-056079
10-K2026-03-27fiscal FY 202536720001213900-26-035576
10-Q2025-11-13fiscal Q3 2025361120001213900-25-110006
10-Q2025-08-13fiscal Q2 2025351070001213900-25-075693
10-Q2025-05-09fiscal Q1 202535720001213900-25-041519
10-K2025-03-28fiscal FY 202435700001013762-25-004139
10-Q2024-11-12fiscal Q3 2024351120001213900-24-096841
10-Q2024-08-13fiscal Q2 2024361120001213900-24-068296
10-Q2024-05-13fiscal Q1 202433690001213900-24-042299
10-K2024-03-25fiscal FY 202333650001213900-24-025615
10-Q2023-11-13fiscal Q3 2023331000001213900-23-086214
10-Q2023-08-11fiscal Q2 202333970001213900-23-066300
10-Q2023-05-12fiscal Q1 202329590001213900-23-039078
10-K2023-03-24fiscal FY 202235670001213900-23-022813
10-Q2022-11-10fiscal Q3 2022351050001213900-22-071252
10-Q2022-08-01fiscal Q2 202233960001213900-22-043390
10-Q2022-05-13fiscal Q1 202233670001213900-22-026450
10-K2022-03-28fiscal FY 202138710001213900-22-015521
10-Q2021-11-10fiscal Q3 2021371040001213900-21-058192
10-Q2021-08-13fiscal Q2 202130830001213900-21-042498
10-Q2021-05-17fiscal Q1 202126530001213900-21-026680
10-K/A2021-05-17fiscal FY 202028550001213900-21-026679
10-K2021-03-29fiscal FY 202028550001213900-21-018270
10-Q2020-11-05fiscal Q3 202025760001213900-20-035267
10-Q2020-08-14fiscal Q2 202026690001213900-20-022078
10-Q2020-05-12fiscal Q1 202023470001213900-20-011867
10-K2020-03-20fiscal FY 201927520001213900-20-007000
10-Q2019-11-13fiscal Q3 201928810001213900-19-023011
10-Q2019-08-13fiscal Q2 201925720001213900-19-015459
10-Q2019-05-14fiscal Q1 201923480001213900-19-008621
10-K2019-04-04fiscal FY 201827470001213900-19-005789
10-Q2018-11-14fiscal Q3 201816370001213900-18-015752
10-K2014-03-31fiscal FY 201312320001213900-14-002019
10-Q2013-11-14fiscal Q3 201314420001213900-13-006399
10-Q2013-08-08fiscal Q2 201314420001213900-13-004042
10-Q2013-05-15fiscal Q1 201314380001213900-13-002541
10-K2013-03-05fiscal FY 201214340001213900-13-000946
10-Q2012-11-13fiscal Q3 201215420001213900-12-006064
10-Q2012-08-01fiscal Q2 201215460001213900-12-004111
10-Q2012-05-15fiscal Q1 201214400001213900-12-002557
10-K2012-01-26fiscal FY 201114350001213900-12-000322
10-Q2011-11-10fiscal Q3 201112350001213900-11-005849
10-Q2011-08-15fiscal Q2 201114320001213900-11-004327

Inspect the source

Entity
SILO PHARMA, INC. / CIK 0001514183
Captured
2026-09-20T09:13:20.337Z
SEC response SHA-256
b55b01ff5b31c52a933a54029f5fe837eae02333bd43de16acad37f51e3b67db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001514183.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))